Exelixis Statistics
NASDAQ: EXELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
58.44+0.11 (+0.19%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 58.44 0.00%
Exelixis by the numbers
Exelixis has a market capitalization of $14.48 billion based on 247.78M shares outstanding. Its trailing P/E ratio is 18.4, below the 5-company peer median of 40.7, and its forward P/E is 13.8. The stock trades 4.4% above its 50-day average and 18.7% above its 200-day average.
Average daily trading volume is 2.33M shares, or about $136.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EXEL valuation vs. peer median
| Metric | EXEL | Peer median | Difference |
|---|---|---|---|
| Market cap | $14.48B | $10.48B | +38% |
| P/E (TTM) | 18.4 | 40.7 | -55% |
| Forward P/E | 13.8 | 31.4 | -56% |
| Avg. volume | 2.33M | 1.71M | +36% |
Peer median across 8 companies: NBIX, HALO, TECH, RGEN, IBRX, TWST, PCVX, KRYS.
Valuation
- Market cap
- $14.48B
- P/E (TTM)
- 18.44
- Forward P/E
- 13.78
- Price / sales (latest FY)
- 6.24
- EPS (TTM)
- $3.17
- Shares outstanding
- 247.78M
Price and trading
- Previous close
- 58.33
- Open
- 58.45
- Day range
- 57.89 – 59.27
- 52-week range
- 33.76 – 61.14
- 52-week change
- +47.46%
- Beta
- —
- Volume
- 2.37M
- Average volume
- 2.33M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 14.48B
- Pe
- 18.44
- Forward Pe
- 13.78
- Eps
- 3.17
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 61.14
- Week52 Low
- 33.76
- Avg Volume
- 2.33M
- Shares Outstanding
- 247.78M
- Ma50
- 55.95
- Ma200
- 49.25
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -4.42%
- Pct From52w Low
- 73.10%